期刊文献+

老年代谢综合征患者趾臂指数与Th17细胞及相关细胞因子的相关性 被引量:2

Association between toe brachial index and Th17 cells and Th17-associated cytok ines in old metabolic syndrome patients
下载PDF
导出
摘要 目的探讨老年代谢综合征患者趾臂指数(TBI)与Th17细胞及其与细胞因子白细胞介素-17(IL-17)、白细胞介素-6(IL-6)及肿瘤坏死因子α(TNF-α)的相关性。方法依据2004年中国糖尿病学会(CDS)提出的标准入选161例代谢综合征患者,应用全自动动脉硬化测定仪VP-1000测定患者的TGBI,将患者分为TBI正常组和TBI降低组。采用流式细胞检测技术检测患者外周血中Th17细胞水平,并采用ELISA法检测所有高血压患者的血清IL-17、IL-6及TNF-α浓度水平。结果 TBI降低组外周血Th17细胞比例明显高于TBI正常组(t=7.116,P<0.01)。TBI降低组Th17细胞因子IL-17、IL-6及TNF-α血清浓度较TBI正常组显著升高(P<0.01)。相关及回归分析显示,TBI与外周血Th17细胞比例、血清IL-17、IL-6及TNF-α血清浓度水平呈负相关(r=-0.443、-0.485、-0.348及-0.429,均P<0.001),Th17细胞比例、IL-17、IL-6、TNF-α血清浓度水平是影响baPWV的主要因素。结论老年代谢综合征患者TBI与Th17细胞及其细胞因子相关。 Objective To investigate the correlations b etween toe brachial index (TBI) and Th17 cells and Th17-associated cytokines in old metabolic syndrome pa tients. Methods According to the standard of metabolic syndrome p resented by Chin ese Diabetes Society in 2004,161 metabolic syndrome patients were eligible recr uited.TBI was observed using VP-1000 automatic atherosclerosis analyzer,and th en the patients were divided into normal TBI group and lower TBI group,respecti vely.Frequencies of peripheral blood Th17 cells were detected using flow cytom etry.And ELISA was used to test serum IL-17,IL-6 and TNF-α. Results The freque ncy of peripheral blood Th17 cells in lower TBI group was higher than that in no rmal TBI group(t= 7.116,P 0.01).Levels of serum IL-17,IL-6 and TN F-α in lo wer TBI group were elevated than those in normal TBI group(P0.01).Th17 cells frequency,IL-17,IL-6 and TNF-α were negatively correlated with TBI(r=-0.443,-0.485,-0.348 and-0.429,P 0.001).Multiple linear regre ssion analysis showed that Th17 cells frequency,IL-17,IL-6 and TNF-α were risk factors of TBI. Conclusions TBI is associated with Th17 cells and Th17-a ssociated cytokines in old metabolic syndrome patients.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2011年第22期4295-4297,共3页 Chinese Journal of Gerontology
基金 山东省自然科学基金项目(ZR2009CL029) 山东省医药卫生计划项目(2009HW080) 山东省医学科学院项目(2009-16、2009-17)
关键词 代谢综合征 趾臂指数 炎症 TH17细胞 细胞因子 Metabolic syndrome Toe brachial index Inflammation Th17 cell Cytokines
  • 相关文献

参考文献15

  • 1Dong C. Genetic controls of Th17 cell differentiation and plasticity [J]. Exp Mol Med ,2011 ;43 ( 1 ) : 1-6.
  • 2侯佳宁,徐敏,黄韵,毕宇芳,顾卫琼,李小英,陈宇红,宁光.2型糖尿病患者趾臂指数(TBI)与动脉粥样硬化的相关性研究[J].中华内分泌代谢杂志,2010,26(3):195-198. 被引量:25
  • 3Hirseh AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease ( lower extrem-ity, renal, mesenteric, and abdominal aortic ) : executive summary [J]. J Am Coil Cardio1,2006 ;47 (6) : 1239-312.
  • 4中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3063
  • 5Orchard TJ, Strandness Jr DE. Assessment of peripheral vascular disease in diabetes. Report and recommendations of an international workshop sponsored by the American Diabetes Association and the American HeartAssociation September 18-20,1992 New Orleans, Louisiana [J]. Circula- tion, 1993 ;88 ( 1 ) :819-28.
  • 6Zhang J, Hua G, Zhang X,et al. Regulatory T cells/T-helper cell 17 func- tional imbalance in uraemic patients on maintenance haemodialysis:a piv- otal link between microinflammation and adverse cardiovascular events[ J]. Nephrologh (Carlton) ,2010 ; 15 ( 1 ) :33-41.
  • 7Cheng X, Yu X, Ding YJ, et al. The Thl7/Treg imbalance in patients with acute coronary syndrome[J]. Clin Immunol,2008 ;127( 1 ) :89-97.
  • 8罗义.亚临床炎症与代谢综合征[J].新医学,2009,40(5):337-339. 被引量:5
  • 9Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis[J]. Circulation ,2002 ; 105 ( 9 ) : 1135-43.
  • 10Pejnovic N, Vratinos A, Lee SH, et al. Increased atherosclerotic lesions and Thl7 in interleukin-18 deficient apolipoprotein E-knockout mice fed high-fat diet[J]. Mol Immunol,2009 ;47 (1) :37-45.

二级参考文献45

  • 1李树彬,ADH IKARICM,高修仁.炎症、炎症介质和代谢综合征[J].新医学,2006,37(2):131-134. 被引量:25
  • 2Tran H,Anand SS.Oral antiplatelet therapy in cerebrovascular disease,coronary artery disease and peripheral arterial disease.JAMA,2004,292:1867-1874.
  • 3Aboyans V,Criqui MH,Denenberg JO,et al.Risk factors for progression of peripheral arterial disease in large and small vessels.Circulation,2006,113:2623-2629.
  • 4Criqui MH,Browner D,Fronek A,et al.Peripheral arterial disease in large vessels is epidemiologically distinct from small vessel disease.An analysis of risk factors.Am J Epidemiol,1989,129:1110-1119.
  • 5Lee AJ,Price JF,Russell MJ,et al.Improved prediction of fatal myocardial infarction using the ankle brachial index in addition to conventional risk factors:the Edinburgh Artery Study.Circulation,2004,110:3075-3080.
  • 6Hirsch AT,Criqui MH,Treat-Jacobson D,et al.Peripheral arterial disease detection,awareness,and treatment in primary care.JAMA,2001,286:1317-1324.
  • 7Hirsch AT,Haskal ZJ,Hertzer NR,et al.ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease(lower extremity,renal,mesenteric,and abdominal aortic):executive summary.J Am Coll Cardiol,2006,47:1239-1312.
  • 8Sahli D,Svensson M,Lidgren J,et al.Evaluation of simple noninvasivetechuiques for assessment of lower extremity arterial disease.Clin Physiol Funct Imaging,2005,25:129-134.
  • 9Orchard TJ,Strandness DE Jr.Assessment of peripheral vascular disease in diabetes.Report and recommendations of an international workshop spensored by the American Diabetes Association and the American Heart Association September 18-20,1992 New Orleans,Louisiana.Circulation,1993,88:819-828.
  • 10Katakami N,Yamasaki Y,Kosugi K,et al.Tissue characterization identifies subjects with high risk of cardiovascular diseases.Diabetes Res Clin Pract,2004,63:93-102.

共引文献3111

同被引文献43

  • 1Sakoda M,Ichihara A,Kurauchi-Mito A,Narita T,Kinou-chi K,Murohashi-Bokuda K,Saleem MA,Nishiyama A,Suzuki F,Itoh H,黄晓斌.在不影响人足细胞(前)肾素受体信号下,阿利吉仑能抑制细胞内血管紧张素Ⅱ水平[J].中华高血压杂志,2010,18(7):698-698. 被引量:18
  • 2Ceriello A,Davidson J,Hanefeld M,et al.Postprandial hyperglycemia and cardiovascular complications of diabetes:an update[J].Nutr Metab Cardiovasc Dis,2006,16:453-456.
  • 3Meigs JB,Nathan DM,S’Agostino RB Sr,et al.Fasting and postchallenge glycemia and cardiovascular disease risk:the Framingham Offspring Study[J].Diabetes Care,2002,25(10):1845-1850.
  • 4Mottillo S,Filion KB,Genest J,et al.The metabolic syndrome and cardiovasular risk a systematic review and meta-analysis[J].J Am Coil Cardiol,2010,56(14):1113-1132.
  • 5Yang XO,Pappu BP,Nurieva R,et al.T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma[J].Immunity.2008,28(1):29-39.
  • 6Laurence A,Tato CM,Davidson TS,et al.Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation[J].Immunity,2007,26(3):371-381.
  • 7Zhang C,Xiao C,Wang P,et al.The alteration of Th1/Th2/Th17/Treg paradigm in patients with type 2 diabetes mellitus:relationship with diabetic nephropathy[J].Hum Immunol,2014,75(4):289-96.
  • 8Nguyen H,Chiasson VL,Chatterjee P,et al.Interleukin-17 causes Rho-kinase-mediated endothelial dysfunction and hypertension[J].Cardiovasc Res,2013,97(4):696-704.
  • 9Tang Y,Bian Z,Zhao L,et al.Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease[J].Clin Exp Immunol,2011,166(2):281-290.
  • 10Vukkadapu SS,Belli JM,Ishii K,et al.Dynamic interaction between T cell-mediatedβ-cell damage andβ-cell repair in the run up to autoimmune diabetes of the NOD mouse[J].Physiol Genomics,2005,21(2):201-211.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部